1 citations
,
May 2022 in “Голова и шея.” This study observed a strong positive association between the expression of the p53 protein and the appearance of dark neurons in the hippocampus of rats following experimental septoplasty, suggesting p53's potential neuroprotective role alongside its activation of damaged neurons.
1 citations
,
May 2022 in “Голова и шея.” This study concluded that the anesthesia protocol using fentanyl, propofol, cisatracuria besylate, tranexamic acid, atropine, and metoclopramide resulted in the least pain during septoplasty.
1 citations
,
May 2022 in “Голова и шея.” This study found that photobiomodulation after septoplasty reduced pain and inflammatory response, leading to less pronounced changes in autonomic nervous system activity compared to patients who did not receive this treatment.
1 citations
,
May 2022 in “Голова и шея.” In this study, researchers found an increase in daily physical activity during the COVID-19 pandemic among students, with a notable rise in leisure walking and transportation, but also increased weekday sedentary behavior in men.
1 citations
,
May 2022 in “Голова и шея.” This study evaluated the quality of life and mental health of patients after moderate traumatic brain injury, reporting changes in physical, mental, and social health as measured by various health scales.
1 citations
,
May 2022 in “Голова и шея.” This study found that septoplasty simulation in rats led to decreased exploratory behavior and anxiety, suggesting a link between postoperative stress and changes in the hippocampal region.
1 citations
,
July 2021 in “Clinical and Experimental Dermatology” This study suggests that finasteride is a safe and effective alternative therapy for women with hidradenitis suppurativa who have contraindications or intolerance to spironolactone.
1 citations
,
April 2019 in “Journal of Investigative Dermatology” This case study describes successful hair growth in a 59-year-old African-American female with central centrifugal cicatricial alopecia after switching to oral minoxidil treatment.
1 citations
,
April 2017 in “Journal of Investigative Dermatology” This study found that oral tofacitinib led to variable hair regrowth in patients with resistant alopecia areata, implying that longer treatment durations may be needed to fully assess its effectiveness.
July 2026 in “Clinical Cosmetic and Investigational Dermatology” In this study, a liposomal-encapsulated Sesbania grandiflora formulation significantly improved hair and scalp health in adults with hair loss over 180 days, showing enhanced hair density, thickness, growth rate, and tensile strength compared to placebo, with no related adverse events reported.
May 2026 in “Frontiers in Medicine” This study concluded that combining the Shumin treatment instrument with oral doxycycline provides better clinical outcomes for rosacea than combining red light therapy with doxycycline, while both regimens improved quality-of-life scores and reduced Demodex counts.
April 2026 in “Frontiers in Medicine” In this case report, a female patient with both psoriasis and lichen planus initially responded to acitretin and topical mometasone but experienced a relapse after stopping the treatment. The authors reported marked improvement within 3 months after switching to upadacitinib, aiming to guide clinical decision-making.
April 2026 in “Dermatology and Therapy” This study reviews the efficacy and safety of advanced therapies like TNFα inhibitors and IL-17/IL-23 inhibitors for dissecting cellulitis of the scalp, finding TNFα inhibitors particularly effective for severe or refractory cases, although prospective validation is needed for early intervention benefits.
March 2026 in “Dermatology and Therapy” This study identified distinct plasma miRNA profiles in alopecia areata that may aid in diagnosis and therapy, but further validation is needed to confirm these exploratory findings.
January 2026 in “Dermatology and Venerology” This study at the Dzerkalo Medical Center found that complex therapy for abscessing perifolliculitis of the scalp is more effective in reducing inflammation and follicle destruction compared to basic antibacterial therapy, which was associated with relapses during long-term follow-up.
December 2025 in “Frontiers in Veterinary Science” This study found that PT-LCG extends hair follicle activity and promotes continuous cashmere growth by enhancing lipid synthesis, remodeling the extracellular matrix, and modulating inflammatory signaling, offering insights into improving cashmere yield and quality through molecular breeding.
November 2025 in “Frontiers in Immunology” This review integrates studies on mouse models and human clinical observations to highlight the role of immune cells in skin development and how their dysregulation leads to skin disorders, suggesting potential therapeutic pathways for skin regeneration.
September 2025 in “Cureus” This review suggests that GLP-1 receptor agonists may improve various dermatologic conditions, but larger studies are needed to confirm these findings.
This case study observed that a patient with multiple refractory inflammatory conditions, including psoriasis, alopecia areata, and psoriatic arthritis, experienced significant improvements after three months of treatment with upadacitinib. The report suggests potential benefits of upadacitinib for similar conditions, recommending further clinical trials.
December 2023 in “University of Southern Denmark Research Portal (University of Southern Denmark)” In this case report, a 9-year-old boy was diagnosed with uncombable hair syndrome following his mother's suspicion and subsequent confirmation via molecular genetics, highlighting how digital access to medical information can raise awareness of rare conditions.
November 2023 in “Research Portal Denmark” This review highlights the variability and unpredictability of alopecia areata, ranging from single scalp patches to total body hair loss, and notes the 2022 approval of the first AA-specific drug, baricitinib, potentially spurring new research into targeted treatments.
February 2023 in “Cosmoderma” This study found that combining red light therapy with oral beta-carotene significantly improved photoaging treatment outcomes compared to red light therapy alone, with Group A showing a 56.12% reduction in photoaging scores over 12 weeks versus 44.78% in Group B.
July 2022 in “Bőrgyógyászati és Venerológiai Szemle” This review discusses recent advancements in mobile technology and artificial intelligence for dermatology, offering an overview of their current applications but reports no new clinical findings.
May 2022 in “Голова и шея.” In this pilot study, researchers observed that low-intensity laser radiation at 445±40 nm increased the temperature of gingival tissues in Wistar rats by 8.37°C without exceeding the safety threshold, suggesting potential for clinical trials.
May 2022 in “Голова и шея.” In this study, the transition from online to full-time education was associated with a worsened emotional state among students, despite already impaired biorhythm indicators during online classes.
May 2022 in “Голова и шея.” This narrative review discusses the challenges and special care needs of laryngectomy patients with tracheoesophageal bypass during the COVID-19 pandemic and reports no new clinical results.
May 2022 in “Голова и шея.” This study examined how a developed distance program of physical education classes affected the cardio-respiratory system of students in a special medical department.
May 2022 in “Голова и шея.” This review discusses the hypothesis of supranormal adaptation related to the evolution of the distal radius and wrist anatomy, reporting no new experimental findings.
May 2022 in “Голова и шея.” This study observed that, in rats, modeling sinus lifting and septoplasty led to increased sympathetic nervous system activity and metabolic shifts in the early postoperative period due to inflammation.
May 2022 in “Голова и шея.” This article highlights exosome-based targeted drug delivery using DARPin G3 proteins as a promising approach for treating aggressive HER2-positive breast cancer but reports no new clinical results.